85 related articles for article (PubMed ID: 29785016)
21. Encapsulated Papillary Carcinoma of Breast: Clinicopathological Features and Prognostic Parameters.
Hashmi AA; Iftikhar SN; Munawar S; Shah A; Irfan M; Ali J
Cureus; 2020 Oct; 12(10):e11282. PubMed ID: 33274157
[TBL] [Abstract][Full Text] [Related]
22. INSM1 immunostaining in solid papillary carcinoma of the breast.
Kudo N; Takano J; Kudoh S; Arima N; Ito T
Pathol Int; 2021 Jan; 71(1):51-59. PubMed ID: 33156579
[TBL] [Abstract][Full Text] [Related]
23. Use of immunohistochemical analysis of CK5/6, CK14, and CK34betaE12 in the differential diagnosis of solid papillary carcinoma in situ from intraductal papilloma with usual ductal hyperplasia of the breast.
Maeda I; Tajima S; Kanemaki Y; Tsugawa K; Takagi M
SAGE Open Med; 2018; 6():2050312118811542. PubMed ID: 30455948
[TBL] [Abstract][Full Text] [Related]
24. Solid Papillary Carcinoma of Breast: Clinicopathologic Comparison With Conventional Ductal Carcinoma of Breast.
Hashmi AA; Iftikhar SN; Haider R; Haider R; Irfan M; Ali J
Cureus; 2020 Oct; 12(10):e11172. PubMed ID: 33262909
[TBL] [Abstract][Full Text] [Related]
25. Intracystic papillary carcinoma: clinical presentation, patterns of practice, and oncological outcomes.
Hassan Z; Boulos F; Abbas J; El Charif MH; Assi H; Sbaity E
Breast Cancer Res Treat; 2020 Jul; 182(2):317-323. PubMed ID: 32462260
[TBL] [Abstract][Full Text] [Related]
26. High Grade Encapsulated Papillary Carcinoma of Breast in a Young Female.
Qureshi MB; Kayani N
J Coll Physicians Surg Pak; 2019 Dec; 29(12):S114-S116. PubMed ID: 31779761
[TBL] [Abstract][Full Text] [Related]
27. Papillary Lesions of the Male Breast: A Study of 117 Cases and Brief Review of the Literature Demonstrate a Broad Clinicopathologic Spectrum.
Zhong E; Cheng E; Goldfischer M; Hoda SA
Am J Surg Pathol; 2020 Jan; 44(1):68-76. PubMed ID: 31403965
[TBL] [Abstract][Full Text] [Related]
28. Breast Tumours Resembling the Tall Cell Variant of Thyroid Papillary Carcinoma: Are They Part of the Papillary Carcinoma Spectrum or a Distinct Entity?
Toss MS; Billingham K; Egbuniwe IU; Moreno F; Abass A; Rakha EA
Pathobiology; 2019; 86(2-3):83-91. PubMed ID: 30308500
[TBL] [Abstract][Full Text] [Related]
29. Solid papillary carcinoma of the breast. A form of intraductal carcinoma with endocrine differentiation frequently associated with mucinous carcinoma.
Maluf HM; Koerner FC
Am J Surg Pathol; 1995 Nov; 19(11):1237-44. PubMed ID: 7573685
[TBL] [Abstract][Full Text] [Related]
30. Breast carcinomas of low malignant potential.
Schnitt SJ; Fend F; Decker T
Virchows Arch; 2022 Jan; 480(1):5-19. PubMed ID: 34292391
[TBL] [Abstract][Full Text] [Related]
31. Case report: Tall cell carcinoma with reversed polarity of the breast: an additional case and review of the literature.
Lei Z; Wang YX; Wang ZY; Yang CG; Pan GQ
Front Oncol; 2024; 14():1302196. PubMed ID: 38434689
[TBL] [Abstract][Full Text] [Related]
32. Solid Papillary Carcinoma with Invasion in the Male Breast: A Case Report and Literature Review.
Hoshina H; Kubouchi K; Takei H
Case Rep Oncol; 2024; 17(1):135-141. PubMed ID: 38283300
[TBL] [Abstract][Full Text] [Related]
33. Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts.
Lauer RC; Barry M; Smith TL; Thomas AM; Wu J; Du R; Lee JH; Rao A; Dobroff AS; Arap MA; Nunes DN; Silva IT; Dias-Neto E; Chen I; McCance DJ; Cavenee WK; Pasqualini R; Arap W
Elife; 2023 Jan; 12():. PubMed ID: 36645410
[TBL] [Abstract][Full Text] [Related]
34. Exome sequencing of affected duos and trios uncovers PRUNE2 as a novel prostate cancer predisposition gene.
Cardoso M; Maia S; Brandão A; Sahasrabudhe R; Lott P; Belter N; Carvajal-Carmona LG; Paulo P; Teixeira MR
Br J Cancer; 2023 Apr; 128(6):1077-1085. PubMed ID: 36564567
[TBL] [Abstract][Full Text] [Related]
35. Codon 172 in the
Sasaki E; Masago K
Gland Surg; 2022 Jun; 11(6):1127-1129. PubMed ID: 35800733
[No Abstract] [Full Text] [Related]
36. OncoSNIPE® Study Protocol, a study of molecular profiles associated with development of resistance in solid cancer patients.
Vachenc S; Gobbo J; Moujarrebe SE; Desmoulins I; Gilabert M; Beau-Faller M; Mitry E; Girard N; Bertaut A; Dusetti N; Iovanna JL; Yousfi R; Pierrat F; Bruno R; Cueff A; Boidot R; Genne P
BMC Cancer; 2022 Jan; 22(1):41. PubMed ID: 34991520
[TBL] [Abstract][Full Text] [Related]
37. Tall cell carcinoma with reversed polarity: case report with gene sequencing and literature review.
Wei Y; Ding L; Song X; Tian X; Min N; Guan Q; Li X; Liu M
Gland Surg; 2021 Nov; 10(11):3147-3154. PubMed ID: 34926230
[TBL] [Abstract][Full Text] [Related]
38. Triple-Negative Breast Cancer Histological Subtypes with a Favourable Prognosis.
Cserni G; Quinn CM; Foschini MP; Bianchi S; Callagy G; Chmielik E; Decker T; Fend F; Kovács A; van Diest PJ; Ellis IO; Rakha E; Tot T; European Working Group For Breast Screening Pathology
Cancers (Basel); 2021 Nov; 13(22):. PubMed ID: 34830849
[TBL] [Abstract][Full Text] [Related]
39. Papillary lesions of the breast.
Kulka J; Madaras L; Floris G; Lax SF
Virchows Arch; 2022 Jan; 480(1):65-84. PubMed ID: 34734332
[TBL] [Abstract][Full Text] [Related]
40. Tall Cell Carcinoma With Reversed Polarity of the Breast.
Matute G; Barcenas L; Bautista C; Restrepo Ramirez CA; Llinas Quintero N
Cureus; 2021 Aug; 13(8):e16814. PubMed ID: 34522474
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
